Susquehanna International Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-94,992
| Closed | -$3.74M | – | 13484 |
|
|
2023
Q2 | $3.74M | Sell |
94,992
-282,755
| -75% | -$9.98M | ﹤0.01% | 4008 |
|
|
2023
Q1 | $9.19M | Buy |
377,747
+335,989
| +805% | +$7.36M | ﹤0.01% | 2573 |
|
|
2022
Q4 | $894K | Sell |
41,758
-270,329
| -87% | -$5.77M | ﹤0.01% | 6425 |
|
|
2022
Q3 | $5.6M | Buy |
312,087
+118,653
| +61% | +$1.56M | ﹤0.01% | 2983 |
|
|
2022
Q2 | $1.86M | Buy |
193,434
+83,398
| +76% | +$1.05M | ﹤0.01% | 5070 |
|
|
2022
Q1 | $1.85M | Sell |
110,036
-33,631
| -23% | -$497K | ﹤0.01% | 5656 |
|
|
2021
Q4 | $2.4M | Buy |
143,667
+54,461
| +61% | +$893K | ﹤0.01% | 5085 |
|
|
2021
Q3 | $1.45M | Buy |
89,206
+49,084
| +122% | +$534K | ﹤0.01% | 6576 |
|
|
2021
Q2 | $253K | Sell |
40,122
-5,107
| -11% | -$32.9K | ﹤0.01% | 11129 |
|
|
2021
Q1 | $280K | Sell |
45,229
-25,158
| -36% | -$153K | ﹤0.01% | 10756 |
|
|
2020
Q4 | $486K | Sell |
70,387
-61,479
| -47% | -$393K | ﹤0.01% | 8355 |
|
|
2020
Q3 | $744K | Buy |
131,866
+68,783
| +109% | +$328K | ﹤0.01% | 6833 |
|
|
2020
Q2 | $322K | Sell |
63,083
-332,390
| -84% | -$1.38M | ﹤0.01% | 8233 |
|
|
2020
Q1 | $1.36M | Buy |
395,473
+208,317
| +111% | +$1.22M | ﹤0.01% | 4691 |
|
|
2019
Q4 | $1.61M | Buy |
+187,156
| New | +$669K | ﹤0.01% | 4684 |
|
|
2019
Q2 | – | Sell |
-10,785
| Closed | -$15K | – | 11021 |
|
|
2019
Q1 | $15K | Sell |
10,785
-17,667
| -62% | -$24.7K | ﹤0.01% | 8625 |
|
|
2018
Q4 | $34K | Sell |
28,452
-13,049
| -31% | -$25.3K | ﹤0.01% | 8587 |
|
|
2018
Q3 | $98K | Sell |
41,501
-30,305
| -42% | -$75.5K | ﹤0.01% | 8612 |
|
|
2018
Q2 | $196K | Buy |
71,806
+17,241
| +32% | +$47.6K | ﹤0.01% | 8627 |
|
|
2018
Q1 | $150K | Sell |
54,565
-8,603
| -14% | -$24.9K | ﹤0.01% | 8526 |
|
|
2017
Q4 | $197K | Buy |
63,168
+6,387
| +11% | +$18K | ﹤0.01% | 8294 |
|
|
2017
Q3 | $160K | Sell |
56,781
-14,536
| -20% | -$39.3K | ﹤0.01% | 8159 |
|
|
2017
Q2 | $183K | Buy |
71,317
+17,209
| +32% | +$46.9K | ﹤0.01% | 8356 |
|
|
2017
Q1 | $198K | Buy |
54,108
+4,993
| +10% | +$21.1K | ﹤0.01% | 8010 |
|
|
2016
Q4 | $237K | Buy |
49,115
+30,856
| +169% | +$916K | ﹤0.01% | 8388 |
|
|
2016
Q3 | $842K | Sell |
18,259
-19,389
| -52% | -$1.09M | ﹤0.01% | 5111 |
|
|
2016
Q2 | $1.92M | Buy |
+37,648
| New | +$1.87M | ﹤0.01% | 3651 |
|
|
2016
Q1 | – | Sell |
-4,181
| Closed | -$213K | – | 9854 |
|
|
2015
Q4 | $328K | Sell |
4,181
-53,606
| -93% | -$3.1M | ﹤0.01% | 7515 |
|
|
2015
Q3 | $2.34M | Buy |
57,787
+30,689
| +113% | +$1.63M | ﹤0.01% | 3970 |
|
|
2015
Q2 | $1.41M | Buy |
27,098
+9,718
| +56% | +$483K | ﹤0.01% | 5458 |
|
|
2015
Q1 | $809K | Buy |
17,380
+2,858
| +20% | +$148K | ﹤0.01% | 6176 |
|
|
2014
Q4 | $652K | Buy |
+14,522
| New | +$610K | ﹤0.01% | 6708 |
|
|
2014
Q3 | – | Sell |
-14,553
| Closed | -$571K | – | 10071 |
|
|
2014
Q2 | $616K | Sell |
14,553
-12,054
| -45% | -$442K | ﹤0.01% | 7078 |
|
|
2014
Q1 | $951K | Buy |
26,607
+17,447
| +190% | +$589K | ﹤0.01% | 5600 |
|
|
2013
Q4 | $296K | Buy |
+9,160
| New | +$272K | ﹤0.01% | 7598 |
|
Susquehanna International Group's ISEE Position: Q3 2023 in Review
Susquehanna International Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 94,992 shares — an estimated $3.74M sold.
Susquehanna International Group first reported a position in ISEE in Q4 2013 and held it in 35 quarters. The position peaked at $9.19M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Susquehanna International Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 94,992 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.74M.
- Susquehanna International Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 35 quarters.
- Susquehanna International Group's IVERIC bio, Inc. Common Stock position peaked at $9.19M in Q1 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.